ALPMF - Astellas Pharma GAAP EPS of ¥28.88 revenue of ¥374.99B August, 01 2023 08:05 AM Astellas Pharma Inc 2023-08-01 08:05:53 ET Astellas Pharma press release ( OTCPK:ALPMF ): Q1 GAAP EPS of ¥28.88. Revenue of ¥374.99B (-1.8% Y/Y). For further details see: Astellas Pharma GAAP EPS of ¥28.88, revenue of ¥374.99B